These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16432856

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
    Leleu X, Soumerai J, Roccaro A, Hatjiharissi E, Hunter ZR, Manning R, Ciccarelli BT, Sacco A, Ioakimidis L, Adamia S, Moreau AS, Patterson CJ, Ghobrial IM, Treon SP.
    J Clin Oncol; 2009 Jan 10; 27(2):250-5. PubMed ID: 19064987
    [Abstract] [Full Text] [Related]

  • 3. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
    Aslan DL, Peterson BA, Long-Tsai M, Eastlund T.
    Transfusion; 2006 Jan 10; 46(1):90-4. PubMed ID: 16398735
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia.
    Weber DM, Dimopoulos MA, Delasalle K, Rankin K, Gavino M, Alexanian R.
    Semin Oncol; 2003 Apr 10; 30(2):243-7. PubMed ID: 12720145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S, Kantarjian H, Keating MJ.
    Ann Oncol; 1996 Apr 10; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [Abstract] [Full Text] [Related]

  • 12. Heterogeneity of histological transformation events in Waldenström's macroglobulinemia (WM) and related disorders.
    Owen RG, Bynoe AG, Varghese A, de Tute RM, Rawstron AC.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 10; 11(1):176-9. PubMed ID: 21856554
    [Abstract] [Full Text] [Related]

  • 13. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
    Jondeau K, Alterescu R, Franc B, Davi F, Massé JM, Boukour S, Le Parc JM, Cramer EM.
    Eur J Haematol; 2006 Jul 10; 77(1):74-9. PubMed ID: 16827885
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
    Dimopoulos MA, Kantarjian H, Weber D, O'Brien S, Estey E, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R.
    J Clin Oncol; 1994 Dec 10; 12(12):2694-8. PubMed ID: 7989946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.